Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TNG908 |
| Synonyms | |
| Therapy Description |
TNG908 is an MTAP-null selective PRMT5 inhibitor, which potentially decreases proliferation of tumor cells harboring MTAP deletion and inhibits tumor growth (PMID: 39756156). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TNG908 | TNG-908|TNG 908 | PRMT5 Inhibitor 21 | TNG908 is an MTAP-null selective PRMT5 inhibitor, which potentially decreases proliferation of tumor cells harboring MTAP deletion and inhibits tumor growth (PMID: 39756156). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05275478 | Phase Ib/II | TNG908 | Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors | Active, not recruiting | USA | FRA | 0 |